Press Releases Archive - Crescendo Biologics

Crescendo Biologics announces early licensing by Takeda of first oncology-targeted Humabody^® View PDF

Crescendo Biologics wins “Biotech Company of the Year” at the Cambridge Independent Science and Technology Awards 2018 View PDF

Crescendo Biologics appoints SVP CMC, Dr Richard Williams, and new CDMO partner, as it advances towards the clinic View PDF

Crescendo Biologics shortlisted for Private Financing Deal of the Year at 2018 Scrip Awards View PDF

Crescendo Biologics shortlisted for Lifestars Awards 2018 View PDF

Crescendo Biologics shortlisted for Cambridge Independent Science and Technology Awards 2018 View PDF

Crescendo Biologics strengthens its management with the appointment of Dr Pavel Pisa as Chief Medical Officer View PDF

Crescendo Biologics reaches technical milestone for a second target in strategic collaboration with Takeda View PDF

Crescendo Biologics appoints clinical development expert, Dr Igor Matushansky, as Non-Executive Director View PDF

Crescendo Biologics appoints Eva-Lotta Allan as Non-Executive Director View PDF

Zai Lab and Crescendo Biologics enter exclusive worldwide license agreement for innovative protein therapeutics for inflammatory indications View PDF

Crescendo Biologics Ltd. raises $70 Million (€57 Million) in Series B Financing View PDF

Crescendo Biologics reaches first major milestone in strategic collaboration with Takeda View PDF

Crescendo Biologics appoints Dani Bach as Non-Executive Director View PDF

Crescendo Biologics to present poster at AACR Annual Meeting 2018, Chicago View PDF

Crescendo Biologics’ Colette Johnston to present at 11th Annual Proteins & Antibodies Congress, London View PDF

Crescendo Biologics’ James Legg to present at 4th Annual Crown Bioscience Cambridge Symposium View PDF

Crescendo Biologics to attend 12th Annual BIO-Europe Spring 2018, Amsterdam View PDF

Crescendo Biologics to attend 36th Annual J.P. Morgan Healthcare Conference 2018, San Francisco View PDF